🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: \- To evaluate the efficacy of daily oral doses of 300 ...
Status
Completed
Location
Investigational Site Number 392010
Start Date
2012-11
Trial ID
NCT01692366
Treatments Being Tested
Primary Objective: \- To evaluate the efficacy of daily oral doses of 300 ...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2011-08
Trial ID
NCT01420770
Treatments Being Tested
The purpose of this study is to evaluate the long-term effects of orally ad...
Status
Completed
Location
Investigational Site Number 840103
Start Date
2008-07
Trial ID
NCT00724334
Treatments Being Tested
Primary Objective: * To evaluate the efficacy of daily oral doses of 400 m...
Status
Terminated
Location
Investigational Site Number 840014
Start Date
2011-12-31
Trial ID
NCT01437787
This is an expanded access program (EAP) for eligible participants designed...
Status
Available
Location
Celgene
Start Date
TBD
Trial ID
NCT03723148
Treatments Being Tested
Primary Objective: * To assess the effect of 15-day repeated oral doses of...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2012-06
Trial ID
NCT01585623
Treatments Being Tested
Primary Objective: \- To assess the effect of SAR302503 (500 mg) administe...
Status
Completed
Location
Investigational Site Number 840003
Start Date
2013-05
Trial ID
NCT01836705
Treatments Being Tested
Primary Objective: \- To evaluate the efficacy of once daily dose of SAR30...
Status
Terminated
Location
Investigational Site Number 840007
Start Date
2012-04-30
Trial ID
NCT01523171
Treatments Being Tested
Primary Objective: * Dose Ranging Phase: To evaluate the efficacy of daily...
Status
Completed
Location
Investigational Site Number 840008
Start Date
2011-10
Trial ID
NCT01420783
Treatments Being Tested
Primary Objective: To study the effect of mild and moderate hepatic impair...
Status
Completed
Location
Investigational Site Number 840003
Start Date
2012-12
Trial ID
NCT01762462
Treatments Being Tested